Clinical Trials Logo

Clinical Trial Summary

This study is conducted to evaluate its morphologic reproliferating patterns in patients with pterygium treated with the excision and conjunctival autograft.


Clinical Trial Description

The medical records of 116 eyes of 116 patients with pterygium who had pterygium excision and conjunctival autograft between February 2009 and May 2011 were reviewed. Using consecutively recorded photographs, we evaluated preoperative morphologic characteristics and its growth patterns. ;


Study Design

Observational Model: Case-Only, Time Perspective: Retrospective


Related Conditions & MeSH terms


NCT number NCT02059837
Study type Observational
Source Kyungpook National University
Contact
Status Completed
Phase N/A
Start date February 2009
Completion date October 2011

See also
  Status Clinical Trial Phase
Recruiting NCT02486484 - Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection Phase 2
Completed NCT02007174 - Bevacizumab Injection for Recurrent Pterygium N/A
Completed NCT05362253 - Micro-Conjunctival Autografting Combined With Amniotic Membrane Transplantation Treating Recurrent Pterygium Trial N/A
Active, not recruiting NCT02530801 - Strategies for Management of Recurrent Pterygium Phase 4
Recruiting NCT04463901 - Conjunctival Autograft or Limbal Conjunctival Autograft for Recurrent Pterygium Using Mitomycin C N/A
Completed NCT01744756 - Subconjunctival Bevacizumab and Recurrent Pterygium Phase 2/Phase 3
Completed NCT01319721 - Recurrent Pterygium Surgery Using Mitomycin C With Limbal Conjunctival or Amniotic Membrane N/A